Report - Newsletter February-2019 · GlaxoSmithKline NA Greenwich Biosciences 1300 Helsinn Therapeutics NA J&J 2000 Kirin 72 Leadiant Biosciences NA Loxo Oncology 860 Merck 500 Mylan 250 NovImmune

Please pass captcha verification before submit form